InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 252762

Saturday, 06/04/2016 12:46:24 AM

Saturday, June 04, 2016 12:46:24 AM

Post# of 346475

Luhrs and Parseghian...interesting duo and just so happened to notice that Parseghian has recent work with 11 authors and one of them at Peregrine ... hmmmmmm...

Pfizer and Allergan and ??? coming soon after Peregrine ? ... but then we have Zhou from Nant Bioscience owned by Patrick Soon-Shiong and hell... maybe they need a few big backers in order to afford to get a stake in Peregrine Pharmaceuticals

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118661335&txt2find=brigitte|phan|patent



Hopefully someone breaks through and exposes the big plan....

now I am curious, how many shares are left 125M 150M 175M to hand over ??

Maybe Novartis should start acquiring PPHM before they get left behind

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News